Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT: TSXV) (TLTFF: OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds (“PDCs”) to destroy cancer, announced today that it has released the video presentations conducted at the end of its Annual General and Special Meeting held on December 9, 2016 in Toronto, Canada.
The presentations were delivered by Dr. Lothar Lilge, Senior Scientist, Princess Margaret Cancer Center, University Health Network (“UHN”) and Dr. Girish Kulkarni, Uro-Oncologist, also from UHN.
